You searched for "infection"
OrCam MyEye – innovative sight assistance (Part 2)
Following on from Part 1 of this topic, we will cover the remaining features, pricing and support of the OrCam MyEye. Facial and person identification The MyEye Pro can be taught to recognise up to 150 individuals (or 75 if...An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment
Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...The fragile p-value
Abdus Samad Ansari explores the limitation of the p-value and the application of the fragility index in clinical trials. Clinical trials and tribulations? The restoration of vision or more purely the gift of sight is an aspect of care that...
Early refractive correction promotes esotropia control
This study sought to determine the incidence and characteristics of esotropia in a Northern Ireland population of children <7 years old in a one-year period. The authors report a 2013 cohort in which the area catchment had 29,365 children under...
Phacoemulsification Cataract Surgery
The book, through a ‘rear-ended’ approach to training, covers basic and fundamental skills for the novice ophthalmic surgeon embarking on phacoemulsification cataract surgery. As the preface states, this is a ‘key surgical technique for an ophthalmologist to learn’. However, achieving...
The effects of anti-VEGF therapy for NvAMD on retinal vasculature
This retrospective consecutive case series examined 54 eyes of 54 treatment-naïve neovascular age-related macular degeneration (N-AMD) patients. Thirty-three eyes received intravitreal aflibercept injections, and 21 eyes received intravitreal ranibizumab injections with unaffected fellow eyes (54 eyes) as controls. All image...
Progression of macular atrophy on long-term anti-VEGF therapy for AMD
This retrospective study evaluated the progression of macular atrophy in 53 eyes of 53 patients receiving AntiVEGF Therapy for age-related macular degeneration (nAMD), for at least six years. None of the patients had any macular atrophy (MA) at presentation. MA...
OCT prognostic factors in AMD patients with peripapillary choroidal neovascularisation
In this retrospective study the authors aimed to investigate the correlation between optical coherence tomography (OCT) findings and visual acuity outcomes after treatment with intravitreal bevacizumab (IVB) injections for age-related macular degeneration (AMD) patients with peripapillary choroidal neovascularisation (PPCNV). Data...
Vision loss during Eylea treatment for AMD
This report investigated patients who lost more than two lines of vision despite periodic injections of aflibercept and explored the factors associated with vision loss. One hundred and ninety-six eyes were included in this study over a two year period....
